80041758EM - Optimal Management of HIV Disease & Hepatitis Clinical Conference (OPMAN XXV) EM

Date & Location
Tuesday, April 11, 2017, 7:00 AM - Tuesday, April 10, 2018, 3:00 PM, Baltimore, MD

Target Audience
Infectious Diseases, Internal Medicine, Nurse Practitioner, Psychiatry, Public Health

For the course contents, please click here .

OPMAN XXV assembles the leading researchers in HIV and hepatitis medicine and provides a unique distillation of data that is clinically focused for practicing HIV and hepatitis healthcare professionals. The conference will feature a highly interactive combination of didactic presentations, case-based learning, and breakout discussions.

  1. Use new information on the pathogenesis of HIV and Viral Hepatitis infection into patient management strategies.
  2. Identify antiretroviral and HBV/HCV antiviral therapies based upon the most recent USPHS, IAS-USA, AASLD, IDSA and EASL Guidelines.
  3. Manage patients with antiretroviral and/or HBV/HCV therapy failure based upon the most recent data presented at CROI (2017), AASLD (2016), Glasgow (2016), International AIDS Conference (2016), ICAAC (2016), IDSA (2016), and EASL (2016) conferences
  4. Use the latest pharmacogenomics/kinetics/dynamics data in managing antiviral (HIV, HBV, HCV) drug interactions, side effects, and complications of treatment.
  5. Evaluate patients for pre-exposure prophylaxis therapy to prevent HIV infection.
  6. Identify and manage patient risk factors for cardiovascular complications of HIV and HIV HBV/HCV co-infected patients.

The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.